MK-677 (Ibutamoren) vs Ipamorelin — Peptide Comparison

MK-677 (Ibutamoren) vs Ipamorelin — Peptide Comparison MK-677 (Ibutamoren) vs Ipamorelin — compare dosing, benefits, safety profiles, side effects, and how they stack. See which peptide is right for you. At a Glance Dose Range MK-677 (Ibutamoren) 10–25 mg Ipamorelin 100–300 mcg Frequency Once daily Multiple times daily Administration Oral (capsule or liquid) Subcutaneous injection Cycle Length 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Efficacy Muscle and body composition Recovery and athletic performance Sleep quality and metabolic health GH Selectivity Recovery Support Safety Profile Technical Data Molecular Formula C27H36N4O5S Molecular Weight 528.7 g/mol Half-Life 4-6 hours (IGF-1 elevation persists ~24 hours) Bioavailability High oral bioavailability CAS Number 159634-47-6 C38H49N9O5 711.85 g/mol 2 hours High when injected subcutaneously 170851-70-4 Protocols starting 10 mg 2-4 weeks initial Lower entry dose used in practice to limit water retention and appetite surge before titrating up. standard 25 mg Studied up to 1-2 years 25 mg once-daily oral is the dose used in the randomized trial in healthy older adults; increased GH/IGF-1 and fat-free mass [1]. Most-studied dose [2]. 100 mcg per injection 2-3 times daily 4-8 weeks Conservative entry dose; Ipamorelin is a selective GH secretagogue with a ~2 hour half-life, so doses are split through the day [1][2]. Used in research and practice to assess tolerance before titrating up. 200 mcg per injection Most commonly cited research/practice dose; gives a meaningful pulsatile GH release without raising cortisol or prolactin at standard doses [1][2]. advanced 300 mcg per injection 3 times daily Upper end of the commonly used range; total daily exposure split across three injections. Used in practice by experienced users [1]. Applications Older Adults (60+) Seeking Body Composition Improvements MK-677 was designed for aging populations. It restores GH and IGF-1 to youthful levels, increases lean mass, and improves physical function in people over 60. A 2-year clinical trial showed a 1.1 kg gain in fat-free mass with only modest fat gain—ideal for maintaining strength in older age. Athletes and Fitness Enthusiasts Wanting Recovery Support Oral dosing makes MK-677 convenient for athletes. It enhances muscle protein synthesis, speeds recovery after intense training, and supports lean mass building without the hassle of injections. People with Chronic Wasting or Protein Deficiency Clinical trials show MK-677 helps treat protein-energy wasting in kidney disease and other conditions. It stimulates appetite (a feature in these populations) and preserves muscle tissue—making it useful for those losing mass despite good nutrition. Clean GH Boost Seekers If you want the benefits of increased growth hormone without spiking cortisol or other stress hormones, Ipamorelin is uniquely selective. Unlike GHRP-2 or GHRP-6, it won't raise your cortisol levels even at doses 200 times higher than needed for GH release. Recovery-Focused Athletes Ipamorelin shines for athletes who want better recovery between training sessions. The GH boost helps repair muscle tissue faster, and since it doesn't mess with other hormones, you can use it consistently without the rollercoaster effects. Anti-Aging Enthusiasts Growth hormone naturally declines as we age, contributing to muscle loss, fat gain, and reduced vitality. Ipamorelin offers a gentle way to restore more youthful GH levels without the risks of actual HGH therapy. Those Recovering from Steroid Use Research shows Ipamorelin can help counteract the muscle and bone-weakening effects of glucocorticoid medications. If you've been on steroids for medical reasons, this peptide may help you rebuild what you've lost. Common Increased appetite Mild water retention or edema Elevated fasting glucose Uncommon Joint or muscle pain Carpal tunnel syndrome or nerve compression symptoms Mild nausea or digestive upset Serious Glucose dysregulation and diabetes risk Mild headache Injection site reactions Water retention Tingling in hands or feet Joint stiffness Allergic reaction Research Status FDA Status Research compound Safety Overview MK-677 has been studied in hundreds of humans over 2+ years and is generally well tolerated. Most side effects are mild and manageable, especially with lower starting doses. The lack of injection requirement makes it safer than injectable GH in terms of infection risk and sterility concerns. However, it is not FDA approved and should be viewed as a research compound. Contraindications xUncontrolled diabetes or severe glucose dysregulation xActive cancer or high cancer risk requiring caution with IGF-1 elevation xPregnancy or breastfeeding Ipamorelin has shown a favorable safety profile in both animal and human studies. What makes it stand out is its remarkable selectivity—it releases growth hormone without significantly affecting cortisol, ACTH, or other hormones. In clinical trials, it was well-tolerated with mostly mild, temporary side effects. Phase 2 trials in patients recovering from surgery showed no significant safety concerns compared to placebo. xActive cancer or history of cancer xPituitary disorders or tumors xKnown allergy to peptide components xChildren and adolescents (growth plates still open) Decision Guide Choose MK-677 (Ibutamoren) if... Building lean muscle mass and strength Improving overall body composition in aging adults Enhancing athletic recovery and performance Supporting metabolic health and fat loss Choose Ipamorelin if... Muscle recovery and growth Anti-aging and vitality Body composition improvement Sleep quality enhancement